Who funds breast cancer research?

We count 85 funded breast cancer projects, active between 2018 and 2031, from 3 funders. The most came from EU · MSCA (23 projects), EU · ERC (22 projects) and EU · Health (12 projects). The median award is $2.4M, across the 77 of 85 projects that list an amount.

Funded projects

85

Funders

3

Median award

$2.4M

Open calls now

4

Top funders of breast cancer research

Projects whose title or summary mentions breast cancer. Median award: of the projects that list an amount, in US dollars; “—” when fewer than 3 do.

Open breast cancer funding calls

4 open calls mention breast cancer today.

• DoW Breast Cancer, Breakthrough Award Levels 1 and 2
  Defense Health Agency Contracting Activity - DHACANot specifiedDeadline: November 18, 2026 ·
• DoW Breast Cancer, Clinical Research Extension Award
  Defense Health Agency Contracting Activity - DHACANot specifiedDeadline: November 18, 2026 ·
• AACR-Male Breast Cancer Global Alliance-Daryl and Christine Soneral Innovation and Discovery Grant for Male Breast Cancer Research
  American Association for Cancer Research (AACR)Up to $50,000Deadline: January 12, 2027 ·
• Breast Cancer Research Foundation-AACR Career Development Awards
  American Association for Cancer Research (AACR)Up to $375,000Deadline: April 1, 2027 ·

Funded breast cancer projects

A sample, latest start first, at most three per program.

• Drinking water PFAS exposure and breast cancer risk
  NIH · NIEHS · $4,387,320 · ends 2030
• Personalized Guidance for Menopausal Hormone Therapy
  NIH · NIA · $3,350,648 · ends 2030
• Evaluating the Impact of Accessible and Scalable Digital Interventions to Address Co-Occurring Insomnia and Depression in Breast Cancer Survivors Using an Adaptive Design
  NIH · NCI · $3,355,681 · ends 2029
• WISDOM: A platform to optimize subtype-specific screening and prevention
  NIH · NCI · $3,329,619 · ends 2029
• Germline variation in homologous recombination repair genes in Hispanic/Latina women to predict breast cancer risk and response to treatment
  NIH · NIMHD · $4,307,388 · ends 2029
• PhD Grant Application: Interactions between IL-18-armoured NKG2D CAR T Cells and the Triple Negative Breast Cancer Microenvironment
  Wellcome · ends 2028
• The impact of chronological ageing on breast tumour initiation
  Wellcome · ends 2028
• Discrete event simulation of private and public comprehensive breast care clinics in South Africa – a case study exploring the economics of stepwise implementation of breast care improvements and resource pooling
  Wellcome · £729,706 · ends 2028
• Leveraging the immune system for breast cancer prevention
  EU · MSCA · ends 2027
• DuoLipo-TNP: Dual-Responsive Liposome Platform for Selective Delivery of Triphosphate Nucleotide Prodrugs in Triple-Negative Breast Cancer
  EU · MSCA · €260,348 · 2027–2029 · CARDIFF UNIVERSITY

How we count

Funded projects come from public award records (NIH RePORTER, NSF, EU CORDIS, UKRI Gateway to Research, Wellcome, the Gates Foundation, DOE, NASA and USDA NIFA) whose title or summary matches “breast cancer”. NIH lists each budget year separately; one project counts once. Amounts are as the funder lists them; medians use only projects that list one, in US dollars. Open calls and forecasts are from our listings of October 28, 2026. A project can mention a topic without being mainly about it, so treat the counts as a guide to who funds the area.